Argatroban

JUL 31, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Argatroban (Labeling)

U.S. Food and Drug Administration

This is an FDA supplemental approval for labeling changes to argatroban; it documents a regulatory action but does not contain clinical trial data or efficacy evidence.

JUN 26, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Argatroban IN 0.9% Sodium Chloride (Labeling)

U.S. Food and Drug Administration

FDA supplemental approval for labeling change to an existing argatroban product; regulatory action, not clinical evidence of efficacy or safety.

JUN 3, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Argatroban IN Dextrose (Labeling)

U.S. Food and Drug Administration

FDA supplemental approval of labeling for an existing argatroban formulation; does not contain clinical trial data or efficacy evidence.

MAY 15, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Argatroban (Labeling)

U.S. Food and Drug Administration

FDA supplemental approval for labeling changes to argatroban; regulatory action without new clinical trial data or efficacy claims.